PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | $44 | $51 | $41 |
| Short-Term Investments | $93 | $98 | $109 | $129 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $3 | $6 |
| Total Curr. Assets | $132 | $145 | $163 | $176 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $6 | $5 | $14 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $8 | $7 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $134 | $153 | $171 | $191 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $4 | $7 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $9 | $6 | $7 |
| Total Curr. Liab. | $12 | $12 | $10 | $14 |
| LT Debt | $1 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $13 | $12 | $11 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$428 | -$407 | -$386 | -$369 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $549 | $548 | $546 | $545 |
| Total Equity | $121 | $141 | $160 | $176 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $134 | $153 | $171 | $191 |
| Net Debt | -$35 | -$43 | -$50 | -$40 |